Compare companies
Selected: 2 of 5
Key figures side by side
| Measure | NORGESFÔR AS2025 | Glaxosmithkline Holding AS2025 |
|---|---|---|
| Sector and size | Handel · Large | Handel |
| Score | 55 rank 9,192 of 22,949 | not ranked |
| Operating revenue | 926 MNOKmedian 1,119 MNOK | not availablemedian 10 MNOK |
| Operating margin | 1.5%median 2.5% | not availablemedian 3.0% |
| Profit margin | 1.4%median 2.5% | not availablemedian 2.6% |
| Return on assets | 11.2%median 10.2% | 10.5%median 8.7% |
| Equity ratio | 28.2%median 30.9% | 64.3%median 33.5% |
| Debt-to-equity | 2.54median 2.23 | 0.55median 1.52 |
| Current ratio | 1.30median 1.30 | 1.00median 1.64 |
| Revenue growth | 23.1%median 6.9% | not availablemedian 5.2% |
| Employees (Enhetsregisteret) | 13 | not available |
The median is each company's own comparison group: same sector, financial year and size group. Source: Brønnøysund Register Centre.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
